<scp>PDGF</scp> beta targeting in cervical cancer cells suggest a fine‐tuning of compensatory signalling pathways to sustain tumourigenic stimulation

Oana Tudoran(Institute of Oncology Prof. Dr. Ion Chiricuta), Ioana Berindan‐Neagoe(Institute of Oncology Prof. Dr. Ion Chiricuta)
Journal of Cellular and Molecular Medicine
October 14, 2014
10.1111/jcmm.12449
Cited by 8

Related Papers

N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration
|Genome biology|2017|130
A Looking-Glass of Non-Coding RNAs in Oral Cancer
|International Journal of Molecular Sciences|2017|67
The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry
|International Journal of Molecular Sciences|2019|67
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
|Scientific Reports|2021|62
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i> -[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile
|Journal of Medicinal Chemistry|2019|57